STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 93 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $129,000 | -58.8% | 26,730 | -9.1% | 0.00% | – |
Q4 2019 | $313,000 | -57.9% | 29,415 | -58.8% | 0.00% | – |
Q3 2019 | $744,000 | -22.5% | 71,425 | +14.0% | 0.00% | – |
Q2 2019 | $960,000 | +15.4% | 62,639 | -3.3% | 0.00% | – |
Q1 2019 | $832,000 | +481.8% | 64,791 | +331.7% | 0.00% | – |
Q4 2018 | $143,000 | -39.7% | 15,008 | +5.3% | 0.00% | – |
Q3 2018 | $237,000 | +10.7% | 14,256 | +6.9% | 0.00% | – |
Q2 2018 | $214,000 | -4.5% | 13,332 | -9.2% | 0.00% | – |
Q1 2018 | $224,000 | -2.6% | 14,678 | -0.8% | 0.00% | – |
Q4 2017 | $230,000 | +37.7% | 14,790 | -1.5% | 0.00% | – |
Q3 2017 | $167,000 | +32.5% | 15,020 | +10.1% | 0.00% | – |
Q2 2017 | $126,000 | +7.7% | 13,647 | 0.0% | 0.00% | – |
Q1 2017 | $117,000 | -16.4% | 13,647 | +3.8% | 0.00% | – |
Q4 2016 | $140,000 | +66.7% | 13,147 | +67.8% | 0.00% | – |
Q3 2016 | $84,000 | +58.5% | 7,834 | 0.0% | 0.00% | – |
Q2 2016 | $53,000 | +47.2% | 7,834 | -4.2% | 0.00% | – |
Q1 2016 | $36,000 | -28.0% | 8,179 | +3.7% | 0.00% | – |
Q4 2015 | $50,000 | -28.6% | 7,889 | +0.1% | 0.00% | – |
Q3 2015 | $70,000 | -30.7% | 7,885 | -8.1% | 0.00% | – |
Q2 2015 | $101,000 | +62.9% | 8,583 | +100.4% | 0.00% | – |
Q1 2015 | $62,000 | +138.5% | 4,282 | +178.6% | 0.00% | – |
Q4 2014 | $26,000 | +36.8% | 1,537 | +0.3% | 0.00% | – |
Q3 2014 | $19,000 | -29.6% | 1,533 | -15.9% | 0.00% | – |
Q2 2014 | $27,000 | – | 1,823 | +60666.7% | 0.00% | – |
Q1 2014 | $0 | – | 3 | 0.0% | 0.00% | – |
Q4 2013 | $0 | -100.0% | 3 | -97.0% | 0.00% | – |
Q3 2013 | $5,000 | – | 101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|